Galera Therapeutics, Inc. (GRTX) Operating income 2018–2025
Galera Therapeutics, Inc. (GRTX) annual operating income history from SEC filings — each fiscal year as reported.
-$2.5MFY2025 · since FY2018: -$24.3M → -$2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.5M | +87.4% |
| FY2024 | -$20.2M | +59.1% |
| FY2023 | -$49.3M | +3.8% |
| FY2022 | -$51.2M | +30.2% |
| FY2021 | -$73.4M | -4.0% |
| FY2020 | -$70.6M | -39.2% |
| FY2019 | -$50.7M | -109.0% |
| FY2018 | -$24.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice